Background Apellis Pharmaceuticals (NASDAQ:APLS), is a US-based commercial biotech focused on innovative biologics that inhibit the complement system via C3 targeting. The firm’s innovative...
The video version of this article was published on Dividend Kings on Tuesday, May 16th. ————————————————————————————— Midstream investors remember the dark days following the...